These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12045159)

  • 21. The year in atherothrombosis.
    Sanz J; Fuster V
    J Am Coll Cardiol; 2011 Aug; 58(8):779-91. PubMed ID: 21835312
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins and stroke prevention: focus on women.
    Bushnell CD
    Ital Heart J; 2004 Aug; 5(8):569-71. PubMed ID: 15554026
    [No Abstract]   [Full Text] [Related]  

  • 23. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group.
    Myers GL; Rifai N; Tracy RP; Roberts WL; Alexander RW; Biasucci LM; Catravas JD; Cole TG; Cooper GR; Khan BV; Kimberly MM; Stein EA; Taubert KA; Warnick GR; Waymack PP; ;
    Circulation; 2004 Dec; 110(25):e545-9. PubMed ID: 15611379
    [No Abstract]   [Full Text] [Related]  

  • 24. Dementia and statins.
    Lowe G; Rumley A; Packard C; Shepherd J
    Lancet; 2001 Mar; 357(9259):881. PubMed ID: 11265975
    [No Abstract]   [Full Text] [Related]  

  • 25. [Statins].
    Kobayashi J
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():618-21. PubMed ID: 17458292
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
    Higashikata T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter by Highton and Khunti Regarding Article, "Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial".
    Highton P; Khunti K
    Circ Cardiovasc Qual Outcomes; 2024 Aug; 17(8):e011189. PubMed ID: 38973473
    [No Abstract]   [Full Text] [Related]  

  • 28. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 29. Dementia and statins.
    Kast RE
    Lancet; 2001 Mar; 357(9259):881. PubMed ID: 11265974
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperlipidemia and primary prevention of stroke: does risk factor identification and reduction really work?
    Lewis A; Segal A
    Curr Atheroscler Rep; 2010 Jul; 12(4):225-9. PubMed ID: 20495893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U; Weintraub WS; Packard CJ
    Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract]   [Full Text] [Related]  

  • 32. [Does JUPITER change the daily routine of our practice?].
    Schlossberg D
    Praxis (Bern 1994); 2009 Mar; 98(6):302. PubMed ID: 19291635
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention, treatment and management of inflammation in atherosclerosis].
    Takemoto M; Yokote K
    Nihon Rinsho; 2011 Jan; 69(1):18-24. PubMed ID: 21226254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.
    Magán-Fernández A; Papay-Ramírez L; Tomás J; Marfil-Álvarez R; Rizzo M; Bravo M; Mesa F
    J Periodontol; 2014 Oct; 85(10):1408-15. PubMed ID: 24555750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.
    Ghanim H; Green K; Abuaysheh S; Patel R; Batra M; Chaudhuri A; Makdissi A; Kuhadiya ND; Dandona P
    Atherosclerosis; 2017 Aug; 263():278-286. PubMed ID: 28711708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Bickel C; Rupprecht HJ; Blankenberg S; Espiniola-Klein C; Schlitt A; Rippin G; Hafner G; Treude R; Othman H; Hofmann KP; Meyer J;
    Am J Cardiol; 2002 Apr; 89(8):901-8. PubMed ID: 11950425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of evidence-based principles of care in older persons (issue 2): management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    J Am Med Dir Assoc; 2006 Mar; 7(3):173-9. PubMed ID: 16503311
    [No Abstract]   [Full Text] [Related]  

  • 38. Polycystic ovary syndrome, inflammation, and statins: do we have the right target?
    Hoeger KM
    J Clin Endocrinol Metab; 2009 Jan; 94(1):35-7. PubMed ID: 19126632
    [No Abstract]   [Full Text] [Related]  

  • 39. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 40. A protein emerges as a heart threat, blunted by statins.
    Heart Advis; 2005 Mar; 8(3):2. PubMed ID: 15895494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.